The development of a series of potent and highly selective casein kinase 1δ/ε (CK1δ/ε) inhibitors is described. Starting from a purine scaffold inhibitor (SR-653234) identified by high throughput screening, we developed a series of potent and highly kinase selective inhibitors, including SR-2890 and SR-3029, which have IC50⩽ 50nM versus CK1δ. The two lead compounds have⩽ 100nM EC50 values in MTT assays against the human A375 ...